U.S. Oil and Gas Stock News

CNB Financial (CCNE) is back on investor watch after reporting second quarter 2026 results on 23 July, followed by a KBW Summer Bank Conference appearance that keeps attention on its earnings profile and loan performance. See our latest analysis for CNB Financial. Since those July updates, CNB Financial’s share price has climbed to $35.10, with a 90 day share price return of 14.41% and a year to date share price return of 36.36%. The 1 year total shareholder return of 60.31% points to...

Oppenheimer Holdings Inc. has reported second-quarter 2026 results, with revenue rising to US$454.88 million and net income reaching US$27.35 million, while its Board declared a US$0.20 per-share quarterly dividend payable on August 28, 2026. Despite much stronger second-quarter profit than a year earlier, net income for the first half of 2026 was only US$6.77 million, highlighting how earlier-period pressures contrast with the recent quarter’s momentum in Wealth Management and Capital...

Graphic Packaging Holding stock has had a difficult run over the past few years, yet the current valuation checks suggest the market may now be pricing it on the cheap side. For investors, the gap between the share price performance and the valuation metrics is what stands out. Over the past 3 years, Graphic Packaging Holding shareholders have seen the stock decline about 50.5%, which signals a heavy reset in market expectations. The key support for the valuation is whether the company can...

After a strong three year run for Okta, where the stock has returned 95.6%, the current valuation picture looks far from a clear bargain as traditional checks flag the shares as expensive even though a Discounted Cash Flow (DCF) intrinsic value estimate points to pricing that is roughly in line with fundamentals. Over the past 3 years, Okta has delivered a 95.6% return, which puts extra focus on whether today’s price still offers enough compensation for risk. Expectations for Okta to keep...

Stevanato Group (STVN) stock is in focus after the company reported that liraglutide combination products using its Alina 30 and Alina 50 pen injectors received marketing authorizations in multiple European countries. See our latest analysis for Stevanato Group. The Alina approvals come as Stevanato Group’s share price shows mixed momentum, with a 30 day share price return of 8.23% and a 90 day share price return of 12.08%. However, the year to date share price return is down 3.55% and the 1...

Sempra stock has delivered a 56.5% total return over the past five years, yet its current checks suggest the shares do not stand out as a clear bargain today. Recent headlines around wildfire liability debates and major LNG project timing give investors fresh reasons to reassess what they are paying for the company’s future cash flows. A 56.5% gain over five years highlights that Sempra has already rewarded long term holders, which can limit how much potential upside remains if expectations...

Zions Bancorporation National Association (NasdaqGS:ZION) announced a 6.7% increase in its quarterly common dividend. The company also authorized a new US$75 million share repurchase program scheduled for the third quarter of 2026. Zions Bancorporation National Association focuses on regional banking services, including lending, deposit gathering, and treasury offerings for businesses and consumers. Dividend decisions and buyback authorizations are closely watched in the banking sector,...

Arcus Biosciences and Summit Therapeutics previously announced a clinical trial collaboration to test Arcus’s oral HIF-2a inhibitor casdatifan with Summit’s PD-1/VEGF bispecific antibody ivonescimab in metastatic clear cell renal cell carcinoma, adding a new combination cohort to Arcus’s ongoing ARC-20 platform study. An interesting aspect of this collaboration is that both companies retain full rights to their own drugs while sharing study costs, potentially expanding each firm’s kidney...

Circle Internet Group (CRCL) has secured a limited purpose trust charter from the New York Department of Financial Services for Circle New York Trust, a development that sharpens the regulatory profile around USDC oversight and custody operations. See our latest analysis for Circle Internet Group. Despite the New York trust charter and earlier approval to establish a national trust bank, Circle Internet Group’s 1-year total shareholder return declined 62.75%, with the share price at $62.61...

Recent commentary around W.W. Grainger (GWW) has focused on expectations for year over year growth in sales and earnings per share ahead of its upcoming quarterly report, giving investors fresh context for the stock. See our latest analysis for W.W. Grainger. Against this backdrop, W.W. Grainger’s share price has climbed 20.34% over the past 90 days and 37.70% year to date, while its 1 year total shareholder return of 49.53% reflects recent performance. If Grainger’s move has you thinking...

Since late July 2026, several law firms, including Kaplan Fox, Pomerantz, and Rosen Law Firm, have launched securities class action lawsuits against GPGI, Inc. over alleged misleading statements tied to its Husky Technologies Limited acquisition and subsequent earnings and guidance updates. These legal actions focus on whether investors were misinformed about the valuation and expected benefits of the Husky deal, raising fresh questions about GPGI’s disclosure practices and...

Allegiant Travel (ALGT) has drawn fresh attention after announcing complimentary inflight beverage service and a new premium seating tier, Allegiant First, aimed at broadening its appeal to leisure travelers across its network. See our latest analysis for Allegiant Travel. The new onboard offerings come after a sharp share price swing for Allegiant Travel, with the stock down 17.69% on a 1 month share price return but up 30.74% over 3 months and a 1 year total shareholder return of 103.82%,...

Host Hotels & Resorts has delivered a 97.7% total return over the past five years, yet valuation checks suggest the stock may still trade below an estimate of its intrinsic value. The key question is how much weight to give a Discounted Cash Flow (DCF) estimate that points to upside versus a broader set of checks that only signal a mixed value picture. A 97.7% return over five years puts Host Hotels & Resorts firmly in the group of stocks that have already rewarded patient shareholders,...

JBG SMITH Properties has seen its share price fall 43.7% over the past five years, yet current valuation work suggests the stock may now be trading below its estimated intrinsic value based on a Discounted Cash Flow (DCF) model and traditional market multiples. The share price decline of 43.7% over five years raises the question of whether sentiment has become more pessimistic than the underlying fundamentals justify. Future cash generation from JBG SMITH Properties' property portfolio can...

The bond market just sent a loud message. The Federal Reserve under Kevin Warsh kept rates on hold, yet long term Treasury yields surged to levels last seen in 2007 while shorter yields eased. At the same time, the Fed’s limited guidance has left investors guessing about inflation and future volatility. For banks and insurers with solid balance sheets, that mix of higher long term rates and shaken Fed credibility can create both openings and traps. This article walks through three financially...

Bank First stock has delivered a 137.8% return over the past 5 years, yet current valuation checks and the latest intrinsic value estimate suggest the shares may now be trading at a premium rather than offering clear value. A 137.8% share price gain over 5 years points to a stock that has already rewarded long term holders, which raises the bar for future returns from today’s price. Recent earnings growth and a higher dividend can support investors’ expectations, while any disappointment in...

AI in healthcare sits at the crossroads of powerful trends that matter for investors, from aging populations and rising treatment costs to central banks wrestling with inflation and bond yields. While higher yields and shifting policy expectations keep pressure on parts of the market, the Transformative AI Healthcare Stocks screener focuses on companies using AI to improve diagnostics, treatment decisions, hospital efficiency and remote care. These tools aim to cut waste, support clinicians...

The new 50% tariff on certain Canadian imports is shaking up cross border trade, and that can ripple through everything from farm exports to grocery shelves. Missouri and other Canada reliant states sit right in the path of this policy change, while sectors like U.S. dairy could see a different set of pressures and openings if trade barriers shift. For investors, the key question is which companies might benefit and which face higher uncertainty. This article looks at three U.S. dairy...

Telephone and Data Systems has more than doubled investors' money over the past three years, yet on the latest checks the stock screens as expensive rather than a clear bargain. That mix of strong multi year returns and a low value score raises questions about how much upside is already reflected in the current US$33.58 share price. The stock has returned 136.4% over three years, which suggests expectations for the business are already running high. Future cash generation from its telecom...

In late July 2026, ExlService Holdings, Inc. reported second-quarter 2026 results showing higher sales of US$594.76 million but slightly lower net income of US$64.51 million versus a year earlier, alongside modestly higher diluted EPS from continuing operations of US$0.42. At the same time, the company raised its full-year 2026 revenue guidance to US$2.39 billion–US$2.42 billion and continued its buyback, pointing to management’s confidence in ExlService’s AI-focused growth initiatives and...

Thermo Fisher Scientific showcased multiple new diagnostic solutions at the 2026 Association for Diagnostics & Laboratory Medicine Annual Meeting. The EXENT Solution secured FDA 510(k) clearance for use in multiple myeloma diagnosis. The EliA CTD 13 Screen gained FDA clearance for systemic autoimmune connective tissue diseases. The company also highlighted previously cleared assays for rapid oncology and preeclampsia testing and previewed new digital tools for lab workflow efficiency. For...

Ares Management (ARES) just reported a busy second quarter, combining record fundraising and higher revenue with fresh dividend declarations for both its common and preferred stock. Investors now have new numbers and payout details to weigh. See our latest analysis for Ares Management. Ares Management’s latest earnings and dividend news landed alongside a sharp 12.73% 1 month share price return and a 7.64% 3 month share price return, yet the stock is still down 22.99% on a year to date share...

Kiniksa Pharmaceuticals International (KNSA) drew fresh attention after it raised its 2026 net product revenue guidance to US$980 million to US$995 million, following second quarter results and a company pipeline update. See our latest analysis for Kiniksa Pharmaceuticals International. Kiniksa Pharmaceuticals International’s recent guidance hike and strong second quarter results have come after a powerful run, with a year to date share price return of 76.98% and a 1 year total shareholder...

Everspin Technologies has delivered a 158.5% share price gain over the past five years, yet the valuation picture is not one sided. A Discounted Cash Flow (DCF) intrinsic value estimate points to a sizable gap relative to the current US$14.53 share price, while broader checks suggest something closer to a mixed verdict than a clear bargain. The 158.5% return over five years highlights that long term holders have already seen a strong payoff. Any further upside case therefore needs to be...